Abstract:Colorectal cancer (CRC) is the third most common type of cancer worldwide. Distant metastasis is the major cause of cancer-related mortality in patients with CRC. Epithelial-mesenchymal transition (EMT) is a critical process triggered during tumor metastasis, which is also the main impetus and the essential access within this duration. Therefore, targeting EMT-related molecular pathways has been considered a novel strategy to explore effective therapeutic agents against metastatic CRC. Traditional Chinese medicines (TCMs) with unique properties multi-target and multi-link that exert their therapeutic efficacies holistically, which could inhibit the invasion and metastasis ability of CRC cells via inhibiting the EMT process by down-regulating transforming growth factor-β (TGF-β)/Smads, PI3K/Akt, NF-κB, Wnt/β-catenin, and Notch signaling pathways. The objective of this review is to summarize and assess the anti-metastatic effect of TCM-originated bioactive compounds and Chinese medicine formulas by mediating EMT-associated signaling pathways in CRC therapy, providing a foundation for further research on the exact mechanisms of action through which TCMs affect EMT transform in CRC.

Research Progress of Epithelial-mesenchymal Transition Treatment and Drug Resistance in Colorectal Cancer

Epithelial–mesenchymal transition in colorectal cancer metastasis: A system review

[Research Progress of the Role of EMT in EGFR-TKIs Resistance of Non-small Cell Lung Cancer].

Epithelial–Mesenchymal Transition-Mediated Tumor Therapeutic Resistance

Epithelial-Mesenchymal Transition and Drug Resistance: Role, Molecular Mechanisms, and Therapeutic Strategies

Targeting Epithelial–Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer

New Insights into the Epithelial-to-Mesenchymal Transition in Cancer

Epithelial–Mesenchymal Transition in Non-Small Cell Lung Cancer Management: Opportunities and Challenges

Tackle Epithelial-Mesenchymal Transition With Epigenetic Drugs in Cancer

Cancer drug resistance induced by EMT: novel therapeutic strategies

Traditional Chinese Medicines as Effective Reversals of Epithelial-Mesenchymal Transition Induced-Metastasis of Colorectal Cancer: Molecular Targets and Mechanisms

Epithelial-Mesenchymal Transition (EMT) as a Therapeutic Target

Epithelial-mesenchymal transition as a therapeutic target for overcoming chemoresistance in pancreatic cancer

Epithelial–mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?

Targeting Epithelial-to-Mesenchymal Transition in Radioresistance: Crosslinked Mechanisms and Strategies

Epithelial–mesenchymal Transition Plays a Critical Role in Drug Resistance of Hepatocellular Carcinoma Cells to Oxaliplatin

Resistance to targeted therapy in metastatic colorectal cancer: Current status and new developments

The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis

Research progress of epithelial-mesenchymal transformation-related transcription factors in peritoneal metastases

The role of epithelial–mesenchymal transition-regulating transcription factors in anti-cancer drug resistance

[Research progress on epithelial-mesenchymal transition in cancer recurrence and metastasis].